The Impact of Goode Health Beverage on Markers of Physiological and Neurocognitive Health
1 other identifier
interventional
22
1 country
2
Brief Summary
The overall research objective of this proposal is to determine the acute and chronic impact of daily supplementation of a Good Health beverage on indices of physiological and neurocognitive health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cardiovascular-diseases
Started Oct 2023
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedFirst Submitted
Initial submission to the registry
January 29, 2024
CompletedFirst Posted
Study publicly available on registry
February 7, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedApril 1, 2025
March 1, 2025
1.3 years
January 29, 2024
March 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Endothelial Function
Flow medicated dilation of the brachial artery
baseline & following 2 weeks of daily beverage consumption
Neurocognitive Function
Performance on the NIH Toolbox Cognitive battery
baseline & following 2 weeks of daily beverage consumption
Peripheral blood pressure (systolic, diastolic, mean)
standard blood pressure measures
baseline & following 2 weeks of daily beverage consumption
Lipid profile (Total-C, LDL-C, VLDL-C, HDL-C, TG)
assessment of lipid profile
baseline & following 2 weeks of daily beverage consumption
Study Arms (2)
Goode Health Beverage
EXPERIMENTALGoode Health Beverage that is high in natural ingredients that are high in Polyphenol 3 content and also have anti-inflammatory and antioxidant properties
Vanilla Base Blend Beverage
PLACEBO COMPARATORThe control beverage is similar but it does not contain the same amount of fiber, anti-inflammatory, and/or antioxidant properties (i.e. mainly smaller or no amounts of flax, ginger, cinnamon, turmeric, berberine bergamot, bilberry, black garlic, and green tea).
Interventions
This is a commercially available beverage powder that is high is healthy ingredients that are believed to be beneficial for physiological health.
This is a commercially available beverage powder.
Eligibility Criteria
You may qualify if:
- Men and women who are between the ages of 18-55
You may not qualify if:
- Any food allergy.
- Pregnant women
- Breast feeding
- Allergies to spandex/lycra.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
UT Arlington - Science and Engineering Innovation and Research Building
Arlington, Texas, 76019, United States
UT Arlington
Arlington, Texas, 76019, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert M Brothers, PhD
University of Texas at Arlington
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- This will be a double-blinded design where the product (experimental of control) will be randomly assigned and given to the participant by a third party individual.
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 29, 2024
First Posted
February 7, 2024
Study Start
October 1, 2023
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
April 1, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share IDP.